[Anti-IgE (Omalizumab): a hope in the treatment of allergic diseases].
Félix Toledo
R
R
Sección de Alergología. Hospital Universitario Virgen de la Arrixaca. Murcia. Spain. rubenfelix@jazzfree.com
Negro Alvarez
J M
JM
D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy; D002986:Clinical Trials as Topic; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D000069444:Omalizumab; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab